Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

AdaptHealth Corp.
Next earnings Aug 3, 2026 (before open) · consensus $0.19 EPS, $866M rev
Last earnings -9.9% on 2026-05-05
Revenue declined -0.5% YoY.
AdaptHealth Corp. shows $3.24B in FY2025 revenue (-0.5% YoY), a -2.2% net margin, and -4.7% ROE.
Sources: SEC EDGAR (CIK 0001725255, latest 10-Q filed 2026-05-05) · EODHD · as of 6/22/2026, 1:44:49 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $2.45B | $2.97B | $3.20B | $3.26B | $3.24B |
| Gross profit | — | — | — | — | — |
| Operating income | $226M | $190M | -$598M | $264M | $90.9M |
| Net income | $156M | $69.3M | -$679M | $90.4M | -$70.8M |
| Diluted EPS | $0.67 | $0.33 | -$5.31 | $0.61 | -$0.52 |
| Net margin | 6.4% | 2.3% | -21.2% | 2.8% | -2.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1483 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 0 open-market buys · 1 sale
| 2026-06-01 | Schuster III Russell E. Chief Commercial Officer | Sell | 11.3K @ $10.06 | $113K |
| 2026-05-27 | McFadden Daniel Edward Chief Operating Officer | Award | 20.1K | |
| 2026-03-20 | CASHIN RICHARD M JR 10% owner | Buy | 447K @ $9.91 | $4.43M |
| 2026-03-19 | CASHIN RICHARD M JR 10% owner | Buy | 727.00 @ $9.94 | $7.23K |
| 2026-03-13 | Prast Albert A. Chief Technology Officer | Exercise | 89.5K @ $4.38 | $392K |
| 2026-03-13 | Prast Albert A. Chief Technology Officer | Tax | 58.2K @ $10.33 | $601K |
| 2026-03-12 | CASHIN RICHARD M JR 10% owner | Buy | 689K @ $9.73 | $6.71M |
| 2026-03-11 | CASHIN RICHARD M JR 10% owner | Buy | 537K @ $9.73 | $5.22M |
| 2026-03-10 | CASHIN RICHARD M JR 10% owner | Buy | 821K @ $9.73 | $7.98M |
| 2026-03-05 | Weaver Susan T Director | Gift | 73.5K | |
| 2026-03-05 | Weaver Susan T Director | Gift | 73.5K | |
| 2026-02-27 | WOLF DALE B Director | Buy | 8.00K @ $8.96 | $71.7K |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.